Journal article · 2017 · Open access

Information when patients participate in a phase I trial: A systematic review.

Katrine Toubro Gad, Ulrik Lassen, P.M. Mau-Soerensen, Mette Terp Høybye, Christoffer Johansen

Journal of Clinical Oncology, 35(5_suppl), 85 · Published 10 February 2017 · DOI 10.1200/jco.2017.35.5_suppl.85

Open full textView at the publisherCite this paper

In brief

“Information when patients participate in a phase I trial: A systematic review.” is a 2017 journal article by Katrine Toubro Gad and 4 co-authors, published in Journal of Clinical Oncology. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read.

Citations
0
Authors
5

Abstract

85 Background: While phase I trials are essential for the development of new anticancer drugs, there is a limited chance of benefitting for cancer patients participating in such trials. The information dialogue is therefore of substantial importance for providing a foundation to make a decision, and the support from relatives of potential value for the patient. This systematic review investigated patients’ prerequisites for deciding to participate in a phase I trial by summarizing the existing knowledge regarding patients’ decision-making when entering a phase I trial, and patients’ and their relatives’ perception of the information prior to enrollment. Methods: The review is based on the principles of Preferred Reporting Items for Systematic Reviews. A comprehensive systematic search was performed using the PubMed, Embase and PsycInfo databases and supplemented by a search for unpublished literature. Results: We identified 36 studies for inclusion in this review. When patients are offered participation in a phase I trial, information procedures as well as the patients’ individual approach influence the decision-making and the perception of the information provided. Across the studies exploring patients’ perception of information, there was a limited understanding of trial purpose and unrealistic expectations of benefit. The relatives’ perception of information remains unexplored. Evaluation of the included studies demonstrated a comprehensive risk of bias in the majority of studies. Conclusions: The information dialogue between physician and the patient concerning participation in a phase I trial seems to benefit from exact information taking account of the perspectives for each individual patient as well as the need for further discussion of trial. While relatives intuitively function as resources for patients entering a phase I trial, this topic is still not investigated.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Gad, K. T., Lassen, U., Mau-Soerensen, P., Høybye, M. T., & Johansen, C. (2017). Information when patients participate in a phase I trial: A systematic review. Journal of Clinical Oncology, 35(5_suppl), 85. https://doi.org/10.1200/jco.2017.35.5_suppl.85

MLA 9

Gad, Katrine Toubro, et al. “Information when patients participate in a phase I trial: A systematic review.” Journal of Clinical Oncology, vol. 35, no. 5_suppl, 2017, p. 85. https://doi.org/10.1200/jco.2017.35.5_suppl.85.

Chicago

Gad, Katrine Toubro, Ulrik Lassen, P.M. Mau-Soerensen, Mette Terp Høybye, and Christoffer Johansen. 2017. “Information when patients participate in a phase I trial: A systematic review.” Journal of Clinical Oncology 35 (5_suppl): 85. https://doi.org/10.1200/jco.2017.35.5_suppl.85.

Harvard

Gad, K. T. et al. (2017) ‘Information when patients participate in a phase I trial: A systematic review.’, Journal of Clinical Oncology, 35(5_suppl), p. 85. doi:10.1200/jco.2017.35.5_suppl.85.

IEEE

K. T. Gad, U. Lassen, P. Mau-Soerensen, M. T. Høybye, and C. Johansen, “Information when patients participate in a phase I trial: A systematic review.,” Journal of Clinical Oncology, vol. 35, no. 5_suppl, p. 85, 2017, doi: 10.1200/jco.2017.35.5_suppl.85.

BibTeX

@article{gad2017information,
  title     = {{Information when patients participate in a phase I trial: A systematic review.}},
  author    = {Gad, Katrine Toubro and Lassen, Ulrik and Mau-Soerensen, P.M. and Høybye, Mette Terp and Johansen, Christoffer},
  journal   = {Journal of Clinical Oncology},
  year      = {2017},
  volume    = {35},
  number    = {5_suppl},
  pages     = {85},
  doi       = {10.1200/jco.2017.35.5_suppl.85},
  url       = {https://doi.org/10.1200/jco.2017.35.5_suppl.85}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research

  • informed consent
  • patient decision-making
  • patient information needs
  • physician-patient communication
  • cancer patients
  • clinical trial participation
  • risk of bias

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Gad, K. T., Lassen, U., Mau-Soerensen, P., Høybye, M. T., & Johansen, C. (2017). Information when patients participate in a phase I trial: A systematic review. Journal of Clinical Oncology, 35(5_suppl), 85. https://doi.org/10.1200/jco.2017.35.5_suppl.85

How many times has this paper been cited?

0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: sign in and open the full text from this page.

Who wrote this paper?

Katrine Toubro Gad, Ulrik Lassen, P.M. Mau-Soerensen, Mette Terp Høybye, Christoffer Johansen.

What is the DOI of this paper?

10.1200/jco.2017.35.5_suppl.85, permanently at https://doi.org/10.1200/jco.2017.35.5_suppl.85. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.